Christine Ménétrier-Caux

6PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersMolecular targetsTumour immunologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 16, 2024
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma.

Olivia Le Saux, Maude Ardin, Justine Berthet

|Jun 28, 2024
Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients.

Stéphane Dalle, Estelle Verronese, Axelle N'Kodia

|Nov 08, 2023
MDR1-EXPRESSING CD4+ T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSE.

Anthony Di Roio, Margaux Hubert, Laurie Besson

|Apr 30, 2021
Recruitment and Expansion of Tregs Cells in the Tumor Environment-How to Target Them?

Justine Cinier, Margaux Hubert, Laurie Besson

|Feb 22, 2020
CD163+ tumor-associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes.

Rodrigo Nalio Ramos, Céline Rodriguez, Margaux Hubert

|Mar 30, 2019
Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?

Christine Ménétrier-Caux, Isabelle Ray-Coquard, Jean-Yves Blay

Pageof 1

Frequent Collaborators

2 joint publications

Anthony Di Roio

1 joint publications

Fábio Laginha

1 joint publications

Nathalie Bendriss-Vermare

1 joint publications

Céline Rodriguez